Case Report: Opportunities for Treatment of Severe COVID-19 Patients-Lessons From a Death Case.

With the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the incidence of coronavirus disease (COVID-19) increases each day. To date, there is no specific anti-SARS-CoV-2 drug. The usual approach to treating COVID-19 is treating its symptoms.

[Nano-silver colloids prepared by electrolysis and research on its SERS activity].

Three kinds of nano-silver colloids have been prepared by electrolysis of silver rod using sodium citrate solution and AgNO3 mixed with polyvinyl alcohol solution as electrolyte and applying 7 V direct current for one hour. Nano-silver colloids have been investigated by means of TEM, absorption spectrum, electrophoresis experiment and SERS. The particle size ranges roughly from 20 nm to 25 nm (spheroid) for sample 1, from 20 nm to 35 nm (spheroid) for sample 2, and from 30 to 80 (many-sided) for sample 3, featuring absorption maximum at 404, 421 and 434 nm, respectively.